Food Science of Animal Resources (한국축산식품학회지)

Korean Society for Food Science of Animal Resources (한국축산식품학회)
권호 표지
DOI QR코드

DOI QR Code

ACE-inhibitory Effect and Physicochemical Characteristics of Yogurt Beverage Fortified with Whey Protein Hydrolysates

  • Lim, Sung-Min (Division of Animal Life Science and Bio/Molecular Informatics Center, Konkuk University) ;
  • Lee, Na-Kyoung (Division of Animal Life Science and Bio/Molecular Informatics Center, Konkuk University) ;
  • Park, Keun-Kyu (Division of Animal Life Science and Bio/Molecular Informatics Center, Konkuk University) ;
  • Yoon, Yoh-Chang (Division of Animal Life Science and Bio/Molecular Informatics Center, Konkuk University) ;
  • Paik, Hyun-Dong (Division of Animal Life Science and Bio/Molecular Informatics Center, Konkuk University)
  • Received : 2011.10.27
  • Accepted : 2011.12.12
  • Published : 2011.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study investigated the ACE-inhibitory effect of yogurt beverage fortified with hydrolysates as well as the suitability of hydrolysates as a nutraceutical additive to yogurt beverage. Three whey protein hydrolysates hydrolyzed by alcalase, protamex, and trypsin were each added to yogurt beverage at concentrations of 1.25, 2.5, and 5 mg/mL. Yogurt beverage fortified with 2.5 mg/mL of hydrolysates had 61-69% ACE-inhibitory activity, whereas yogurt beverage fortified with 5 mg/mL of hydrolysates showed 74% ACE-inhibitory activity. There were no significant differences in ACE-inhibitory activity between the alcalase or protamex hydrolysates during storage; however, trypsin hydrolysate exhibited significant differences. On the other hand, physicochemical characteristics such as pH (3.47-3.77), titratable acidity (0.81-0.84%), colority, viable cell count, and sensory qualities were not significantly different among the tested yogurt beverage samples during storage. These results showed that yogurt beverage fortified with whey protein hydrolysates maintained antihypertensive activity and underwent no unfavorable changes in physicochemical characteristics regardless of enzyme type.

Keywords

References

  1. AOAC (1995) Official methods of analysis. 16th ed, Association of Official Analytical Chemists, Washington, DC, USA.
  2. Ariyoshi, Y. (1993) Angiotensin-converting enzyme inhibitor derived from food protein. Trends Food Sci. Technol. 4, 139-144. https://doi.org/10.1016/0924-2244(93)90033-7
  3. Campbell, D. J. (2003) The renin-angiotensin and the kallikrein-kinin systems. Int. J. Biochem. Cell Biotechnol. 35, 784-791. https://doi.org/10.1016/S1357-2725(02)00262-5
  4. Christensen, J. E., Dudley, E. G., Pederson, J. A., and Steele, J. L. (1999) Peptidases and amino acid catabolism in lactic acid bacteria. Antonie van Leeuwenhoek 76, 217-246. https://doi.org/10.1023/A:1002001919720
  5. Clare, A. and Swaisgood, H. E. (2000) Bioactive milk peptides: a prospectus. J. Dairy Sci. 86, 1187-1195.
  6. Cushman, D. W. and Cheung, H. S. (1971) Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 20, 1637-1648. https://doi.org/10.1016/0006-2952(71)90292-9
  7. Donkor, O. N., Henriksson, A., Vasiljevic, T., and Shah, N. P. (2007) Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of viability and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk. Lait 87, 21-38. https://doi.org/10.1051/lait:2006023
  8. FitzGerald, R. J. and Murray, B. A. (2006) Bioactive peptides and lactic fermentations. Int. J. Dairy Technol. 59, 118-125. https://doi.org/10.1111/j.1471-0307.2006.00250.x
  9. Fuglsang, A., Nilsson, D., and Nyborg, N. C. B. (2002) Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats. Appl. Environ. Microbiol. 68, 3566-3569. https://doi.org/10.1128/AEM.68.7.3566-3569.2002
  10. Fujita, H., Yamagami, T., and Ohshima, K. (2001) Effects of an ACE inhibitory agent, katsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline and mildly hypertensive subjects. Nutr. Res. 21, 1149-1158. https://doi.org/10.1016/S0271-5317(01)00333-5
  11. Jang, A. and Lee, M. (2005) Purification and identification of angiotensin converting enzyme inhibitory peptides from beef hydrolysates. Meat Sci. 69, 653-661. https://doi.org/10.1016/j.meatsci.2004.10.014
  12. Kim, S. B., Seo, I. S., Khan, M. A., Ki, K. S., Nam, M. S., and Kim, H. S. (2007) Separation of iron-binding protein from whey through enzymatic hydrolysis. Int. Dairy J. 17, 625-631. https://doi.org/10.1016/j.idairyj.2006.09.001
  13. Korhonen, H. J. T. and Pihlanto, A. (2006) Bioactive peptides: Production and functionality. Int. Dairy J. 16, 945-960. https://doi.org/10.1016/j.idairyj.2005.10.012
  14. Kunji, E. R. S., Mierau, I., Hagting, A., Poolman, B., and Konings, W. N. (1996) The proteolytic systems of lactic acid bacteria. Antonie van Leeuwenhoek 70, 187-221. https://doi.org/10.1007/BF00395933
  15. Lopez-Fandino, R., Otte J., and van Camp, J. (2006) Physiological, chemical and technological aspects of milk-proteinderived peptides with antihypertensive and ACE-inhibitory activity. Int. Dairy J. 16, 1277-1293. https://doi.org/10.1016/j.idairyj.2006.06.004
  16. Minervini, F., Algaron, F., Rizzello, C. G., Fox, P. F., Monnet, V., and Gobbetti, M. (2003) Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Appl. Environ. Microbiol. 69, 5297-5305. https://doi.org/10.1128/AEM.69.9.5297-5305.2003
  17. Nicholas, J. A. and Eric, C. R. (1996) Characterization of casein phosphopeptides prepared using alcalase. Enzyme Microb. Technol. 19, 202-207. https://doi.org/10.1016/0141-0229(95)00232-4
  18. Otte, J., Qvist, K. B., Pedersen, M., Vogensen, F. K., and Flambard, B. (2003) ACE-inhibitory activity of fermented milks: Effects of culture and protein concentration. Poster at the Conference Milk Proteins: Quality and Health Aspects., Wadahl, Norway, pp. 13-16.
  19. Pihlanto-Leppala, A., Koskinen, P., Piilola, K., Tupasela, T., and Korhonen, H. (2000) Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides. J. Dairy Res. 67, 53-64. https://doi.org/10.1017/S0022029999003982
  20. SAS (1999) SAS/STAT Software for PC. SAS Institute Inc., Cary, NC, USA.
  21. Seppo, L., Jauhiainen, T., Poussa, T., and Korpela, R. (2003) A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77, 326-330.
  22. Shah, N. P. (2000) Effect of milk-derived bioactives: An overview. Br. J. Nutr. 84, S3-S10.
  23. Silvia, S. V. and Malcata, F. X. (2005) Caseins as source of bioactive peptides. Int. Dairy J. 15, 1-15. https://doi.org/10.1016/j.idairyj.2004.04.009
  24. Sinha, R., Radha, C., Prakash, J., and Kaul, P. (2007) Whey protein hydrolysate: Functional properties, nutritional quality and utilization in beverage formulation. Food Chem. 101, 1484-1491. https://doi.org/10.1016/j.foodchem.2006.04.021
  25. Van der Ven, C., Grupen, H., Bont, D. B. A., and Voragen, A. G. J. (2002) Optimization of the angiotensin converting enzyme inhibition by whey protein hydrolysates using response surface methodology. Int. Dairy J. 12, 813-820. https://doi.org/10.1016/S0958-6946(02)00077-8
  26. Vermeirssen, V., Van Camp, J., Devos, L., and Verstraete, W. (2003) Release of angiotensin I converting enzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: From batch experiment to semicontinuous model. J. Agri. Food Chem. 51, 5680-5687. https://doi.org/10.1021/jf034097v
  27. Yamamoto, N. (1997) Antihypertensive peptides derived from food proteins. Biopolymers 43, 129-134. https://doi.org/10.1002/(SICI)1097-0282(1997)43:2<129::AID-BIP5>3.0.CO;2-X
  28. Yamamoto, N., Akino, A., and Takano, T. (1994) Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 77, 917-922. https://doi.org/10.3168/jds.S0022-0302(94)77026-0
  29. Yusuf, S., Lonn, E., Bosch, J., and Gerstein, H. (1999) Summary of randomised trials of angiotensin converting enzyme inhibitors. Clin. Exp. Hypertens. 21, 835-845. https://doi.org/10.3109/10641969909061013

Cited by

  1. Proteolytic and angiotensin-converting enzyme-inhibitory activities of selected probiotic bacteria vol.51, pp.4, 2016, https://doi.org/10.1111/ijfs.13054
  2. Strategies of producing bioactive peptides from milk proteins to functionalize fermented milk products vol.63, 2014, https://doi.org/10.1016/j.foodres.2014.06.002
  3. Physicochemical characterization of hydrolysates of whey protein concentrates for their use in nutritional beverages vol.24, pp.4, 2015, https://doi.org/10.1007/s10068-015-0171-3
  4. Effect of Flavourzyme®on Angiotensin-Converting Enzyme Inhibitory Peptides Formed in Skim Milk and Whey Protein Concentrate during Fermentation byLactobacillus helveticus vol.81, pp.1, 2016, https://doi.org/10.1111/1750-3841.13177
  5. Comparative analysis of mozzarella cheeses fortified with whey protein hydrolysates, diverse in hydrolysis time and concentrations vol.53, pp.9, 2016, https://doi.org/10.1007/s13197-016-2336-3
  6. Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension vol.57, pp.13, 2017, https://doi.org/10.1080/10408398.2015.1068736
  7. Peptide Analysis and the Bioactivity of Whey Protein Hydrolysates from Cheese Whey with Several Enzymes vol.37, pp.1, 2011, https://doi.org/10.5851/kosfa.2017.37.1.62